Dr. Ram Sheetgrah Profile
Key Indicators
- Authorised Capital ₹ 2.21 Cr
as on 28-12-2024
- Paid Up Capital ₹ 2.20 Cr
as on 28-12-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 Cr
as on 28-12-2024
- Satisfied Charges ₹ 12.83 Cr
as on 28-12-2024
- Revenue 4.77%
(FY 2022)
- Profit 62.11%
(FY 2022)
- Ebitda 1.41%
(FY 2022)
- Net Worth 2.20%
(FY 2022)
- Total Assets -17.02%
(FY 2022)
About Dr. Ram Sheetgrah
The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.21 Cr and a paid-up capital of Rs 2.20 Cr.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹12.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pawan Agrawal, Rajni Agarwal, Barkha Agarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U15139UP2007PTC033851
- Company No.
033851
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Ram Sheetgrah?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Agrawal  | Director | 28-Oct-2014 | Current |
| Rajni Agarwal | Director | 19-Dec-2014 | Current |
| Barkha Agarwal | Director | 11-Jan-2018 | Current |
| Vipin Agarwal | Director | 19-Dec-2014 | Current |
Financial Performance of Dr. Ram Sheetgrah.
Dr. Ram Sheetgrah Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.77% increase. The company also saw a substantial improvement in profitability, with a 62.11% increase in profit. The company's net worth moved up by a moderate rise of 2.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Ram Sheetgrah?
In 2019, Dr. Ram Sheetgrah had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Feb 2024 | ₹4.00 Cr | Open |
Canara Bank Creation Date: 20 Oct 2015 | ₹2.50 Cr | Satisfied |
Canara Bank Creation Date: 23 Feb 2015 | ₹1.40 M | Satisfied |
How Many Employees Work at Dr. Ram Sheetgrah?
Unlock and access historical data on people associated with Dr. Ram Sheetgrah, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Ram Sheetgrah, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Ram Sheetgrah's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
